Aerobic glycolysis is the most important metabolic feature of cancer cells. It can not only provide energy for the continuous proliferation of cancer cells but also the metabolites of the glycolysis pathway can participate in other metabolic pathways and serve as raw materials for the synthesis of biological macromolecules. Therefore, understanding the glycolytic state of cancer cells is of great significance for the regulation of glucose metabolism in cancer cells and the development of new drugs targeting glycolysis in cancer cells.
CD BioGlyco can provide a comprehensive real-time analysis of cancer glycolytic pathways based on the MOPCGM platform. We can help customers accurately analyze the metabolites involved in the glycolytic pathway, the activities of metabolic enzymes, and the expression, modification, and interaction of glycolytic-related proteins.
CD BioGlyco provides multi-omics analysis for cancer cell glycolysis, including genomics, proteomics, metabolomics, and metabolic fluxomics, to help customers gain a comprehensive understanding of cancer cell glycolysis pathways. Our experienced teams of scientists, researchers, and technicians provide fast turnaround, high-quality services at competitive prices for worldwide customers. Our customers have direct access to our staff and prompt feedback on their inquiries. If you are interested in our services, please contact us for more details.
